全文获取类型
收费全文 | 22931篇 |
免费 | 1753篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 226篇 |
儿科学 | 915篇 |
妇产科学 | 595篇 |
基础医学 | 3081篇 |
口腔科学 | 672篇 |
临床医学 | 2668篇 |
内科学 | 4474篇 |
皮肤病学 | 350篇 |
神经病学 | 1819篇 |
特种医学 | 964篇 |
外科学 | 3127篇 |
综合类 | 387篇 |
一般理论 | 43篇 |
预防医学 | 2152篇 |
眼科学 | 345篇 |
药学 | 1402篇 |
1篇 | |
中国医学 | 16篇 |
肿瘤学 | 1492篇 |
出版年
2022年 | 142篇 |
2021年 | 334篇 |
2020年 | 232篇 |
2019年 | 369篇 |
2018年 | 410篇 |
2017年 | 341篇 |
2016年 | 354篇 |
2015年 | 434篇 |
2014年 | 604篇 |
2013年 | 785篇 |
2012年 | 1124篇 |
2011年 | 1221篇 |
2010年 | 673篇 |
2009年 | 593篇 |
2008年 | 1090篇 |
2007年 | 1181篇 |
2006年 | 1110篇 |
2005年 | 1096篇 |
2004年 | 961篇 |
2003年 | 951篇 |
2002年 | 815篇 |
2001年 | 641篇 |
2000年 | 628篇 |
1999年 | 528篇 |
1998年 | 265篇 |
1997年 | 232篇 |
1996年 | 237篇 |
1995年 | 240篇 |
1994年 | 218篇 |
1993年 | 201篇 |
1992年 | 474篇 |
1991年 | 460篇 |
1990年 | 440篇 |
1989年 | 444篇 |
1988年 | 406篇 |
1987年 | 372篇 |
1986年 | 315篇 |
1985年 | 384篇 |
1984年 | 294篇 |
1983年 | 265篇 |
1982年 | 163篇 |
1979年 | 212篇 |
1978年 | 185篇 |
1977年 | 153篇 |
1976年 | 151篇 |
1975年 | 159篇 |
1974年 | 160篇 |
1973年 | 198篇 |
1972年 | 159篇 |
1971年 | 143篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
Venkatesan Chakrapani Thilakavathi Subramanian Pandara Purayil Vijin Ruban Nelson Murali Shunmugam Trace Kershaw 《Global public health》2020,15(3):438-451
ABSTRACTHIV-positive men who have sex with men (HIV+MSM) in India need culturally-relevant interventions to promote safer sex. We tested a multi-level intervention among HIV+MSM that targeted individual, interpersonal, and community factors, based on the Social-Personal and Social Ecological Models. We conducted a 2?×?2 factorial RCT with 119 HIV+MSM randomised to receive either an individual-level intervention (ILI) using motivational interviewing to promote safer sex, a community-level intervention (CLI) to strengthen community norms toward safer sex and reduce stigma among MSM communities, a multi-level intervention combining the individual- and community-level interventions (ILI?+?CLI), or standard-of-care control. Participants completed pre- and post-intervention assessments of a composite sexual risk score and a process evaluation to assess fidelity and satisfaction. Out of the 119 HIV+MSM, 106 (89.0%) completed pre- and post-intervention assessments. Generalised Estimating Equation models showed that both CLI (Incidence Rate Ratio [IRR]?=?.67, 95% CI .47 to .96) and ILI?+?CLI (IRR?=?.66, 95% CI .48 to .91) groups had a statistically significant decrease in sexual risk compared to the standard-of-care. The interventions had high levels of fidelity and satisfaction. This pilot RCT demonstrated feasibility and potential effectiveness of a multi-level intervention that addresses individual, interpersonal and community-level contributors of sexual risk among HIV+MSM. 相似文献
3.
Sarah Hallas Andrea Nelson Susan O'Meara Una Adderley Pauline Meskell Jane Nixon Aonghus O'Loughlin Sebastian Probst Wael Tawfick Thomas Wild Georgina Gethin 《Journal of tissue viability》2021,30(3):317-323
BackgroundA venous leg ulcer is a chronic leg wound caused by poor venous blood circulation in the lower limbs. It is a recurring condition causing pain, malodour, reduced mobility, and depression. Randomised controlled trials evaluating treatments for venous leg ulcers provide important evidence to inform clinical decision-making. However, for findings to be useful, outcomes need to be clinically meaningful, consistently reported across trials, and fully reported. Research has identified the large number of outcomes reported in venous leg ulcer trials, impacting both synthesis of results, and clinical decision-making. To address this, a core outcome set will be developed. A core outcome set is an agreed standardised set of outcomes which should be, as a minimum, measured and reported in all trials which evaluate treatment effectiveness for a given indication. A core outcome set has the potential to reduce research waste, improve the utility of RCTs, reduce reporting bias, facilitate treatment comparisons across different sources of evidence and expedite the production of systematic reviews, meta-analyses and evidence-based clinical guidelines.AimThe aim of this project is to develop a core outcome set for research evaluating the effectiveness of interventions for treating venous leg ulceration.MethodsThrough a scoping review of the literature on venous leg ulceration, we will firstly identify a list of candidate outcome domains (broad categories in relation to what is being measured) from randomised controlled trials and qualitative research, and outcomes (specific methods in relation to what is being measured). In two further stages, we will use the resulting lists of outcome domains and outcomes to design two online surveys. A range of stakeholders will be invited to participate in the surveys and they will be asked to indicate which outcome domains and outcomes are most important and should be considered as core in future research reports. 相似文献
4.
5.
6.
7.
8.
9.
Nelson G Ordó?ez 《Modern pathology》2006,19(1):34-48
The histologic distinction between peritoneal epithelioid mesotheliomas and serous carcinomas diffusely involving the peritoneum may be difficult, but it can be facilitated by the use of immunohistochemistry and electron microscopy. D2-40 and podoplanin are two recently recognized lymphatic endothelial markers that can be expressed in normal mesothelial cells and mesotheliomas. The purpose of this study is to compare the value of these new mesothelial markers with those that are commonly used for discriminating between mesotheliomas and serous carcinomas, and also to determine the current role of electron microscopy in distinguishing between these malignancies. A total of 40 peritoneal epithelioid mesotheliomas and 45 serous carcinomas of the ovary (15 primary, 30 metastatic to the peritoneum) were investigated for the expression of the following markers: D2-40, podoplanin, calretinin, keratin 5/6, thrombomodulin, MOC-31, Ber-EP4, B72.3 (TAG-72), BG-8 (Lewis(Y)), CA19-9, and leu-M1 (CD15). All 40 (100%) of the mesotheliomas reacted for calretinin, 93% for D2-40, 93% for podoplanin, 93% for keratin 5/6, 73% for thrombomodulin, 13% for Ber-EP4, 5% for MOC-31, 3% for BG-8, and none for B72.3, CA19-9, or leu-M1. All 45 (100%) serous carcinomas were positive for Ber-EP4, 98% for MOC-31, 73% for B72.3, 73% for BG-8, 67% for CA19-9, 58% for leu-M1, 31% for keratin 5/6, 31% for calretinin, 13% for D2-40, 13% for podoplanin, and 4% for thrombomodulin. After analyzing the results, it is concluded that Ber-EP4 and MOC-31 are the best negative mesothelioma markers for differentiating between epithelioid mesotheliomas and serous carcinomas. The best discriminators among the positive markers for mesotheliomas are D2-40, podoplanin, and calretinin. From a practical point of view, Ber-EP4 and MOC-31, in combination with calretinin, and/or D2-40 or podoplanin allow the differential diagnosis to be established between mesothelioma and serous carcinoma in nearly all instances. As a clear distinction could be made between these two malignancies in all of the cases in which electron microscopy was performed, this technique can be very useful in establishing the correct diagnosis when the immunohistochemical results are equivocal or further support of a diagnosis of either mesothelioma or serous carcinoma is needed. 相似文献
10.